CNTY-104

N/A

Report date: 2025/07/18 17:53:57

Base Information

Drug NameCNTY-104
Drug Alias NameCNTY104
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicityNatural killer cell replacements
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentury Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCentury Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A